Advancing the Science

Mayo Clinic Medical Science Blog

Items Tagged ‘Forefront’

February 16th, 2017

Drug combo safe for diffuse large B-cell lymphoma

By Nicole Brudos Ferrara nicoleferrara

  Drugs targeting the P13K-mTOR pathway add benefit when combined with standard R-CHOP therapy.   The drug everolimus can be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma, according to the results of a pilot study by Mayo Clinic researchers. The researchers published their study findings in the July 2016 issue of […]

View full entry · Comment on this

Tags: diffuse large B-cell lymphoma, Dr Patrick Johnston, everolimus, Forefront, lymphoma, Mayo Clinic Cancer Center, non-Hodgkin lymphoma, R-CHOP


February 5th, 2017

Researchers identify unique breast microbiome

By Nicole Brudos Ferrara nicoleferrara

A team of Mayo Clinic researchers has identified evidence of bacteria in breast tissue and found differences between women with and without breast cancer. These research findings were published in the August 3, 2016, issue of Scientific Reports. “Our research found that breast tissue samples obtained in the operating room under sterile conditions contain bacterial […]

View full entry · Comment on this

Tags: Breast Cancer, Dr Amy Degnim, Dr Nick Chia, Dr Tina Hieken, Forefront, Mayo Clinic Cancer Center, microbiome


January 17th, 2017

Avoid routine double mastectomy when possible

By Elizabeth Zimmermann Young elizabethzimmermann

Consensus group urges weighing pros, cons and patient preference in unilateral breast cancer. A position paper issued by the American Society of Breast Surgeons recommends against contralateral prophylactic mastectomy (CPM) for average-risk women with breast cancer in only one breast. The recommendation on prophylactic mastectomy, published online July 28, 2016, in the Annals of Surgical […]

View full entry · Comment on this

Tags: American Society of Breast Surgeons, Breast Cancer, double mastectomy, Forefront, Judy Boughey, Mayo Clinic Cancer Center


January 10th, 2017

Meet the Investigator: Jamie N. Bakkum-Gamez, M.D.

By Elizabeth Zimmermann Young elizabethzimmermann

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Jamie N. Bakkum-Gamez, M.D., a gynecologic oncologist at Mayo Clinic in Rochester, Minnesota, discusses her research. This is one of a series of Meet the Investigator interviews […]

View full entry · Comment on this

Tags: Alan Bryce, cancer research, Forefront, Jamie Bakkum-Gamez, Joseph Mikhael, Mayo Clinic Cancer Center, Meet the Investigator, Minetta Liu, richard joseph


January 5th, 2017

Stool DNA test added to colorectal screening

By Elizabeth Zimmermann Young elizabethzimmermann

Updated guidelines make noninvasive colorectal cancer screening option available to millions.   The U.S. Preventive Services Task Force has issued its final colorectal cancer screening recommendations for 2016. The task force assigns an overall “A” grade to colorectal cancer screening in people ages 50 to 75 and fully recommends several screening exams that now include […]

View full entry · Comment on this

Tags: Cologuard, colon cancer, David Ahlquist, Forefront, US Preventive Services Task Force


December 29th, 2016

Drug combo stems tumor growth in lung cancer

By Nicole Brudos Ferrara nicoleferrara

Researchers on Mayo Clinic’s campus in Jacksonville, Florida, have shut down one of the most common and lethal forms of lung cancer by combining the rheumatoid arthritis drug auranofin with an experimental targeted agent. The combination therapy worked in a laboratory study to stop lung adenocarcinoma associated with mutation of the KRAS gene. The study […]

View full entry · Comment on this

Tags: Alan Fields, auranofin, cancer stem cells, chemotherapy, Florida, KRAS gene, Lung Cancer, PKCiota, Forefront


December 13th, 2016

Nipple-sparing mastectomy may be a good option

By Elizabeth Zimmermann Young elizabethzimmermann

Technique offers a safe way to reduce breast cancer risk in carriers of the BRCA mutation. Mastectomies that preserve the nipple and surrounding skin prevent breast cancer as effectively as do more-invasive surgeries for women with a genetic mutation called BRCA, a multi-institution study led by Mayo Clinic Cancer CenterĀ found. The study findings were presented […]

View full entry · Comment on this

Tags: BRCA, Breast Cancer, Forefront, James Jakub, mastectomy, Mayo Clinic Cancer Center, nipple-sparing


Contact Us · Privacy Policy